Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Bullboard Posts
Comment by Sandman852on Aug 03, 2018 11:23pm
141 Views
Post# 28413931

RE:RE:RE:RE:RE:RE:RE:RE:RE:letter from GA today - note point #4 highlighted

RE:RE:RE:RE:RE:RE:RE:RE:RE:letter from GA today - note point #4 highlightedbingo !  The points I was making were that first there is NO statement that either system is an actual sale. they simply talk about delivery and instalation. More likely that they are testing the product to VERIFY that this tech is superior to other tech including the echoinsight etc.  It was noteworthy that the Maz had all these technologies, so ideally they are the best info source.  
      Now that being the case, its likely hospitals etc will wait to see how superior the vpt tech is -hoping it is...before they commit any funds -now that there may be alternate soluions.  
Hence the delay in sales / committments and the impact on sp.  
    IF they prove their case, the rest will take care of itself . As for lending money, 3rd party financing / leasing is available from many sources and easily approved for hospitals / clinics etc. In fact VPT should offer financing by setting up that option with a national lender / finance source.  
   kudos to GA for his integrity
Bullboard Posts